Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1262) | |||||
|---|---|---|---|---|---|
| DME Name | Unclear metabolic mechanism (DME-unclear), Enterorhabdus mucosicola | ||||
| Gene Name | DME-unclear | ||||
| Lineage | Species: Enterorhabdus mucosicola (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Drugs in Phase 4 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
Daidzein |
Drug Info | Phase 4 | Dyslipidaemia | ICD11: 5C81 | [1] |
| Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 2 Drugs | ||||
Dihydrodaidzein |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [1] |
Dihydrogenistein |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [1] |
| References | |||||
|---|---|---|---|---|---|
| 1 | Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol. 2008 Aug;74(15):4847-52. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.